| Jared Zimmerman, DDS | |
|
215 S Pine St, Newton, KS 67114-3745 | |
| (316) 283-6103 | |
| (316) 283-1333 |
| Full Name | Jared Zimmerman |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 215 S Pine St, Newton, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841603602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 61104 (Kansas) | Secondary |
| 1223G0001X | Dentist - General Practice | 2014016851 (Missouri) | Primary |
| Entity Name | Health Ministries Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346261930 PECOS PAC ID: 1254330244 Enrollment ID: O20061221000130 |
News Archive
Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells).
U.S. Health and Human Services Secretary Kathleen Sebelius has broad legal authority to waive Medicaid maintenance-of-effort requirements, according to a memo from the Congressional Research Service to the U.S. Senate Finance Committee.
Roche Diagnostics announced today the opening of a new west-coast customer training center in Pleasanton, California, as part of an initiative to make state-of-the-art training on diagnostic equipment more accessible to hospitals and independent laboratories on the west and east coasts.
The latest research for sports-related concussion and sudden cardiac death in athletes, in addition to a record number of sports medicine research submissions, will be presented by members of the American Medical Society for Sports Medicine at the 2013 AMSSM Annual Meeting.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it was expanding its Phase 2 clinical trial of STA-9090 in patients with Stage IIIB and Stage IV non-small cell lung cancer (NSCLC) from up to 69 patients to up to 146 patients based on encouraging activity observed in the first stage of the two stage clinical trial.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jared Zimmerman, DDS 720 Medical Center Dr, Newton, KS 67114-8778 Ph: (316) 283-6103 | Jared Zimmerman, DDS 215 S Pine St, Newton, KS 67114-3745 Ph: (316) 283-6103 |
News Archive
Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells).
U.S. Health and Human Services Secretary Kathleen Sebelius has broad legal authority to waive Medicaid maintenance-of-effort requirements, according to a memo from the Congressional Research Service to the U.S. Senate Finance Committee.
Roche Diagnostics announced today the opening of a new west-coast customer training center in Pleasanton, California, as part of an initiative to make state-of-the-art training on diagnostic equipment more accessible to hospitals and independent laboratories on the west and east coasts.
The latest research for sports-related concussion and sudden cardiac death in athletes, in addition to a record number of sports medicine research submissions, will be presented by members of the American Medical Society for Sports Medicine at the 2013 AMSSM Annual Meeting.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it was expanding its Phase 2 clinical trial of STA-9090 in patients with Stage IIIB and Stage IV non-small cell lung cancer (NSCLC) from up to 69 patients to up to 146 patients based on encouraging activity observed in the first stage of the two stage clinical trial.
› Verified 2 days ago
Mackenzie Reed, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 431 Victoria Rd, Newton, KS 67114 Phone: 316-283-2970 | |
Dr. Thomas Joseph Kruse I, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1021 Washington Rd, Suite 200, Newton, KS 67114 Phone: 316-283-4850 | |
Dr. Harold Gregg, Dentist Medicare: Not Enrolled in Medicare Practice Location: 301 N Main St, Suite 104, Newton, KS 67114 Phone: 316-283-2690 | |
Phillip Tippin, Dentist Medicare: Not Enrolled in Medicare Practice Location: 431 Victoria Rd, Newton, KS 67114 Phone: 316-283-2970 | |
Gerald A Vinduska, DDS Dentist Medicare: Medicare Enrolled Practice Location: 215 S Pine St, Newton, KS 67114 Phone: 316-804-7785 Fax: 316-283-1333 | |
Adam Fischer Lukens, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 209 S. Pine St., Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-0453 | |
Terry L. Davidson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 120 W 6th St, Newton, KS 67114 Phone: 316-283-0110 Fax: 316-283-0736 |